Skip to content

Discipline: Reumatologie

Reumatologie team

Reumatologie, therapie vandaag en de uitdagingen van morgen

Voor de meest frequent voorkomende reumatologische aandoeningen kunnen nieuwe therapieën de komende jaren wellicht weinig meerwaarde bieden ten opzichte van…


Reumatologen gaan de strijd aan met het volledige spectrum van reumatologische aandoeningen

Qua behandelingsopties onderging reumatologie als discipline een ware revolutie in de voorbije twee decennia. De heterogeniteit van reumatische aandoeningen laat…

Actuele behandelingen bij reumatoïde artritis

Actuele behandelingen bij reumatoïde artritis

De afgelopen jaren zijn de behandelingsmogelijkheden bij reumatoïde artritis (RA) expansief toegenomen. We onderscheiden Disease Modifying Antirheumatic Drugs (DMARDs) en…


Poussée sévère d’une dermatomyosite pré-existante chez une patiente avec un adénocarcinome pulmonaire traité par pembrolizumab, un anti-PD-1 [Life-threatening flare of an underlying «paraneoplastic» dermatomyositis in a patient with lung adenocarcinoma treated with anti-PD-1 pembrolizuma].

Rev Med Liege. 2022 Jul;77(7-8):462-467. French. PMID: 35924504.

Myositis specific and associated autoantibodies (MSA-ab).

Neuromuscul Disord. 2022 Jul;32(7):594-608. doi: 10.1016/j.nmd.2022.05.011. Epub 2022 May 20. PMID: 35644723.

Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases.

Autoimmun Rev. 2022 Apr 11:103087. doi: 10.1016/j.autrev.2022.103087. PMID: 35421608 Review.

Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases.

Clin Exp Rheumatol. 2022 Mar 11. doi: 10.55563/clinexprheumatol/v1e7s2. Online ahead of print. PMID: 35349418

Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up.

J Transl Autoimmun. 2022 Feb 11;5:100148. doi: 10.1016/j.jtauto.2022.100148. eCollection 2022.PMID: 35243286

Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.

Clin Exp Rheumatol. 2022 Feb;40(2):274-283. Epub 2022 Feb 16.PMID: 35200123

Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern.

Ann Rheum Dis. 2022 Jan 13:annrheumdis-2021-220004. doi: 10.1136/annrheumdis-2021-220004.

Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.

Semin Arthritis Rheum. 2021 Aug 1;51(5):969-976. doi: 10.1016/j.semarthrit.2021.07.018.

Idiopathische inflammatoire myopathieën (deel 1, 2 en 3).

Tijdschrift voor geneeskunde. REUMATOLOGIE 2021, Volume 1, DOI: 10.47671/TVG.77.20.168

Development of eosinophilic fasciitis during treatment with certolizumab pegol for ankylosing spondylitis.

Clin Exp Rheumatol. 2020 Jul-Aug;38(4):799.

Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.

Clin Exp Rheumatol. 2019 Jul 4.

Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review.

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

Autoimmun Rev. 2019 Mar;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004. Epub 2019 Jan 11. Review.

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients.

Nat Commun. 2019 Jan 2;10(1):9. doi: 10.1038/s41467-018-07911-6.

Correlative imaging in crowned dens syndrome.

Clin Nucl Med. 2007 Nov;32(11):854-7. PubMed PMID: 18075419.

Anakinra in resistant gout: a case report.

Acta Clin Belg. 2016 Oct 7:1-3. [Epub ahead of print] PubMed PMID: 27712511.

Assessment of sensitivity to change of the European Scleroderma Study Group activity index.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):148-151. PubMed PMID: 27463733.

Disease activity indices in systemic sclerosis: a systematic literature review.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):186-192. Review. PubMed PMID: 27385265.

EULAR Study Group on Microcirculation in Rheumatic Diseases. Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis.

Microcirculation. 2016 Jul;23(5):364-72. doi: 10.1111/micc.12281. Review. PubMed PMID: 27086648.

Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.

Int J Cardiol. 2016 Jun 1;212:265-73. doi: 10.1016/j.ijcard.2016.03.084. PubMed PMID: 27057932.

Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.

J Rheumatol. 2016 May;43(5):995-6. doi: 10.3899/jrheum.151018. PubMed PMID:27134280.

The heart and pulmonary arterial hypertension in systemic sclerosis.

Acta Clin Belg. 2016 Feb;71(1):1-18. doi: 10.1080/17843286.2015.1108538. PubMed PMID: 27075793.

IgG4-related disease: The utility of (18)F-FDG PET/CT in diagnosis and treatment.

Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:155-9. PubMed PMID: 26672716.

Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

J Rheumatol. 2013 Dec;40(12):2023-8. doi: 10.3899/jrheum.130528. PubMed PMID: 24128778.

Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.

J Rheumatol. 2013 Jan;40(1):52-7. doi: 10.3899/jrheum.120778. PubMed PMID: 23118116.

Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement?

Ann Rheum Dis. 2012 Oct;71(10):1636-9. doi: 10.1136/annrheumdis-2011-200780. Epub


Allogeneic stem cell transplantation in refractory rheuma toid arthritis: A case report.


KBVR Working group on rare connective tissue diseases: Where are we and where do we want to go?


Myositis specific and associated autoantibodies (MSA-ab).

Hoofddorp, The Netherlands

Workshop on electromyography.


Systemic diseases.


Physicians’ reasons for prescribing Janus kinase inhibitors (JAKi) in patients with rheumatoidarthritis, and associated alignment between physicians and patients in a real-world clinical setting.


A rare case of adult-onset phalangeal microgeodic syndrome.


hysician and patient attitudes towards treat-to-target, its implementation and stated treatment goals in patients with rheumatoid arthritis in a real-world setting across Europe.


Prevalence of clinical symptoms and laboratory markers in idiopathic inflammatory myopathies.

virtual edition, 2021

The impact of temperature on the evaluation of myositis specific antibodies by lineblot.


Fast track algorithm: how to differentiate a scleroderma pattern from a non-scleroderma pattern.


Case report.


20th Belgian Congres on Rheumatology. Quiz.


Rare cases of bone fragility or disorders (case reports).

La Hulpe

Assessment of Sensitivity to Change of the Disease Activity Score (DAS) in Systemic Sclerosis (SSc).


Four years follow-up of an open-label pilot study of treatment with rituximab in patients with early, diffuse cutaneous systemic sclerosis.


Two years follow-up results of a multicenter, open-label pilot study with rituximab in patients with early, diffuse cutaneous systemic sclerosis.


Stabilisation of microcirculation in patients with early systemic sclerosis with diffuse skin involvement treated with rituximab.

Oostende + San Diego

Synovial fluid derived invariant Natural Killer T cells in chronic arthritides show an increased Programmed Death-1 expression and anerghic phenotype.

La Hulpe

Two years follow-up results of an open pilot study of fixed repeated treatment with rituximab in patients with “early” systemic sclerosis with diffuse skin involvement.

Antwerpen + Chicago
Back To Top